Back to Search
Start Over
The pharmacological mechanisms of omalizumab in patients with very high IgE levels—Clues from studies on atopic dermatitis
- Source :
- Dermatologica Sinica, Vol 30, Iss 4, Pp 147-153 (2012)
- Publication Year :
- 2012
- Publisher :
- Wolters Kluwer Medknow Publications, 2012.
-
Abstract
- Seventeen case series investigating the effects of omalizumab on patients with atopic dermatitis included patients whose pretreatment serum IgE was above 700 IU/ml, the upper inclusion limit specified in the product label. In all, 107 patients received omalizumab at doses of ≤375 mg every 2 weeks, which is recommended for patients with IgE
Details
- Language :
- English
- ISSN :
- 10278117
- Volume :
- 30
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Dermatologica Sinica
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.987ea825a5d54423ae5e29e86a241273
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.dsi.2012.10.001